INM Competitors & Alternatives

Compare InMed Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

INM

Main Stock
$1.57
Tradestie Score
55
Market Cap
$5.29M
Revenue Growth
-0.3%
Analyst Upside
+1173.9%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.06
$711.32M - 53 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 55 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.34
$543.32M - 58 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.21
$237.15M 7.2 60 Compare
BIOA BioAge Labs, Inc. Common Stock
$21.79
$212.23M - 55 Compare
PALI Palisade Bio, Inc. Common Stock
$1.89
$12.21M 16.3 52 Compare
ENSC Ensysce Biosciences, Inc. Common Stock
$0.28
$7.21M - 51 Compare
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares
$4.23
$4.25M - 49 Compare
REVB Revelation Biosciences, Inc. Common Stock
$0.99
$3.42M - 43 Compare
NUWE Nuwellis, Inc. Common Stock
$2.80
$2.90M - 52 Compare

Data updated: Jul 14, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry